EXCLUSIVE: GOP Rep Unveils Bill To Prevent Federal Dollars From Subsidizing Sex Change Surgeries

Republican South Dakota Rep. Dusty Johnson will introduce legislation Tuesday to bar healthcare entities from using some federal dollars to subsidize sex change surgeries and hormone replacement therapies.

Johnson’s No 340B Savings for Transgender Care Act would prohibit healthcare entities from using savings under the 340B drug pricing program to offer free or discounted sex change procedures to uninsured or low-income Americans. The legislation would ensure that healthcare entities are not pushing left-wing gender ideology with savings derived from participation in the program, according to background on the bill obtained by the 🏢Daily Caller News Foundation.

📺 Embedded media — coming soon

Congress created the 340B program in 1992 to stretch eligible healthcare entities’ federal dollars by requiring drug manufacturers participating in Medicaid to sell discounted drugs to eligible healthcare entities, which allows them to use the derived savings to provide additional services and expand healthcare access. Some healthcare entities in blue states, such as Howard Brown Health in Chicago, Illinois, have publicized that they use their 340B savings on sex-altering procedures, including “hormone therapy, group therapy and gender-affirming surgical navigation.”

Between 2018 and 2023, 16 states funneled more than $165 million in funding to so-called “gender-transition services,” including so-called puberty blockers and sex change surgeries.

Sex-altering procedures are especially expensive for uninsured patients, ranging from up to $15,000 for just genital reconstruction, to $50,000 for genital reconstruction, facial alteration and breast removal,